Press Release- Crescent Womb has received initial approval for research grant funding from the National Science Foundation (NSF) to continue their research for their Crescent Womb™ device as a treatment for plagiocephaly (flathead syndrome) in infants.

FOR IMMEDIATE RELEASE

Contact: James Spencer hello@crescentwomb.com

PINELLAS COUNTY, FLORIDA- June 1st 2021

Crescent Womb has received initial approval for research grant funding from the National Science Foundation (NSF) to continue their research for their Crescent Womb™ device as a treatment for plagiocephaly (flathead syndrome) in infants. As of June 1st 2021, the group has submitted all final proposal budget documents for final approval. Their goal is to leverage the NSF program to systematically apply this knowledge toward the production of useful innovations to solve this underserved issue. This development is significant because it allows the company to further explore research and development avenues to successfully indicate that Crescent Womb™ can be used as a highly effective solution for prevention and correction of PPB in infants. Besides the obvious cosmetic issues associated with the disorder, several studies have also now reported associations between PPB and mental developmental delays, making means for prevention for important than ever before.

Crescent Womb has successfully developed multiple innovations for early childhood health and safety. Their team holds multiple forms of Intellectual Property protections including patents both granted and pending with imminent approval.

About Crescent Womb

Crescent Womb is pioneering innovations for early childhood health and safety. They are committed to providing ALL families with accessible solutions to common ailments. Crescent Womb’s message and products are a catalyst to change the conversation around the difficult topics of co-sleeping, SIDS, and overall quality of life.

###